Key result
Bariatric surgery was associated with a significant mean decrease of 4.23 mm (95% CI 3.23-5.2; p<0.001) in fat-infiltrated axillary lymph node size.
Why the study?
Ectopic fat deposition in obesity associates with organ dysfunction, but little is known regarding fat deposition within the lymphatic system and related lymphatic dysfunction.
Does bariatric surgery reduce the size of fat-infiltrated axillary lymph nodes in women?
Cohort (n=84)
Does bariatric surgery reduce the size of fat-infiltrated axillary lymph nodes in women?
Mean Difference: 4.23 (95% CI 3.23–5.2)
p-value: p=< 0.001
Bariatric surgery significantly reduces the size of fat-infiltrated axillary lymph nodes, an effect that is associated with the resolution of dyslipidemia independent of weight loss.
Should not yet alter axillary node evaluation post-bariatric surgery; leaves open links to dyslipidemia resolution independent of weight loss.
Background: Ectopic fat deposition in obesity is associated with organ dysfunction; however, little is known about fat deposition within the lymphatic system and associated lymphatic dysfunction. Methods: One hundred fifty-five women who underwent routine screening mammography before and after a Roux-en-y gastric bypass or a sleeve gastrectomy were retrospectively reviewed and after excluding women without visible nodes both before and after bariatric surgery, 84 patients were included in the final analysis. Axillary lymph node size, patient weight in kilograms, body mass index, and a diagnosis of hypertension, type 2 diabetes, and dyslipidemia were evaluated before and after surgery. Binary linear regression models and Fischer’s exact test were used to evaluate the relationship between the size of fat-infiltrated axillary lymph nodes, patient age, change in patient weight, and diagnosis of hypertension, type 2 diabetes, and dyslipidemia. Results: Fat-infiltrated axillary lymph nodes demonstrated a statistically significant decrease in size after bariatric surgery with a mean decrease of 4.23 mm (95% CI: 3.23 to 5.2, p < 0.001). The resolution of dyslipidemia was associated with a decrease in lymph node size independent of weight loss (p = 0.006). Conclusions: Mammographically visualized fat-infiltrated axillary lymph nodes demonstrated a statistically significant decrease in size after bariatric surgery. The decrease in lymph node size was significantly associated with the resolution of dyslipidemia, independent of weight loss, age, and type of surgery.
No takes yet. Share an insight, caveat, or question.
Dwan et al. (2022) conducted a cohort in Obesity (n=84). Bariatric surgery vs. Pre-surgery baseline was evaluated on Change in size of fat-infiltrated axillary lymph nodes (MD 4.23 mm, 95% CI 3.23 to 5.2, p=< 0.001). Bariatric surgery was associated with a significant mean decrease of 4.23 mm (95% CI 3.23-5.2; p<0.001) in fat-infiltrated axillary lymph node size.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: